Fig. 4From: Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513Metabolic profile as measured by oxygen consumption rate (OCR) and extracellular acidification rate (ECAR). OZ513 studied after an 18Â h pre-treatment at a concentration of 500Â ng/ml. Control was media alone and experimental group was treatment with OZ513Back to article page